Clinical Trial

Post-Market Clinical Follow-Up Study on the Safety and Performance of Ennovate® Cervical

Study acronym: CERISE
Recruiting
View on ClinicalTrials.gov →
Summary
Multicenter Post market clinical follow-up Study on the Safety and Performance of Ennovate® Cervical - Prospective, pure data collection of all Ennovate Cervical patients in Total Indications
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-06 -> 2027-08 2026-08-04
minor Completion pushed: 2026-07 -> 2028-09 2026-08-04
Trial Details
NCT Number NCT05296889
Lead Sponsor Aesculap AG
Collaborators: Raylytic GmbH
Conditions Spine Fracture, Degenerative Disc Disease, Spinal Instability, Spinal Tumor, Degenerative Myelopathy
Enrollment 200 participants
Start Date 2021-07-21
Primary Completion 2027-08 (estimated)
Study Completion 2028-09 (estimated)
Updated on ClinicalTrials.gov 2026-08-03